David Weiner's most recent trade in Inovio Pharmaceuticals Inc was a trade of 2,167 Restricted Stock Unit done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 86,620 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 84,453 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 972 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 83,481 (0%) | 0% | - | Common Stock | |
| Ladder Capital Corp - Ordi... | David Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 6,438 | 42,210 (0%) | 0% | 0 | Class A Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 82,509 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | B. David Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David Weiner B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 79,371 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Weiner B. David | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 80,343 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | B. Weiner David | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 972 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David Weiner B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 1,944 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 78,399 (0%) | 0% | - | Common Stock | |
| Ladder Capital Corp - Ordi... | David Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 7,109 | 35,772 (0%) | 0% | 0 | Class A Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 929,124 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 11,666 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 11,666 | 915,957 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 11 Mar 2023 | 5,833 | 910,124 (0%) | 0% | 1.2 | 6,708 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 60,000 | 60,000 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 26 Feb 2023 | 11,668 | 904,291 (0%) | 0% | 1.3 | 14,935 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 23,333 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 11,666 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 915,959 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 904,292 (0%) | 0% | - | Common Stock | |
| Ladder Capital Corp - Ordi... | David Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 6,505 | 28,663 (0%) | 0% | 0 | Class A Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 11,875 | 11,875 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 11 Aug 2022 | 11,875 | 892,625 (0%) | 0% | 2.7 | 31,588 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.16 per share. | 11 Aug 2022 | 11,875 | 904,500 (0%) | 0% | 2.2 | 25,650 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 901,625 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 13 May 2022 | 9,000 | 892,625 (0%) | 0% | 2.0 | 17,550 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 11,667 | 11,666 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 11,667 | 887,708 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 3.20 per share. | 11 Mar 2022 | 4,083 | 883,625 (0%) | 0% | 3.2 | 13,066 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 11,666 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 11,666 | 880,124 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 3.33 per share. | 08 Mar 2022 | 4,083 | 876,041 (0%) | 0% | 3.3 | 13,596 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 60,000 | 60,000 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 11,667 | 23,333 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 11,667 | 868,458 (0%) | 0% | - | Common Stock | |
| Ladder Capital Corp - Ordi... | David Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 6,372 | 22,158 (0%) | 0% | 0 | Class A Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 859,836 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 13 May 2021 | 3,045 | 856,791 (0%) | 0% | 6.6 | 20,158 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2021 | 22,500 | 0 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 21 Apr 2021 | 22,500 | 855,219 (0%) | 0% | 8.6 | 192,825 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.40 per share. | 21 Apr 2021 | 22,500 | 877,719 (0%) | 0% | 2.4 | 54,000 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 8.54 per share. | 21 Apr 2021 | 4,083 | 851,136 (0%) | 0% | 8.5 | 34,869 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 11,667 | 23,333 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 11,667 | 855,219 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 11,667 | 11,666 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 11,667 | 847,052 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 11,666 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 11,666 | 838,885 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 9.60 per share. | 05 Mar 2021 | 3,500 | 843,552 (0%) | 0% | 9.6 | 33,601 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 9.18 per share. | 05 Mar 2021 | 3,500 | 835,385 (0%) | 0% | 9.2 | 32,135 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 60,000 | 60,000 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
| Ladder Capital Corp - Ordi... | David Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,212 | 15,786 (0%) | 0% | 0 | Class A Common Stock | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 15 Dec 2020 | 17,500 | 827,219 (0%) | 0% | 10.7 | 187,352 | Common Stock |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 17,500 | 0 | - | - | Common Stock Option | |
| Inovio Pharmaceuticals Inc | David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.56 per share. | 15 Dec 2020 | 17,500 | 844,719 (0%) | 0% | 4.6 | 79,800 | Common Stock |